Patents by Inventor Nikolas Pietrzik

Nikolas Pietrzik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240027454
    Abstract: The disclosed technology relates to chemical entities for the detection of wounds, e.g., chronic wounds or infected wounds, including compositions, substrates, kits, dressing materials, and articles, and systems containing such compounds. The disclosed technology further relates to methods of using these compositions, kits and systems in diagnostic assays, and in the diagnosis and/or detection of chronic or infected wounds based on enzymatic action on specific moieties and/or reaction sites. The disclosed technology additionally relates to detection of pathogenic, e.g., bacterial and/or viral substances, such as enzymes and substrates, at the wound situs. Additional disclosure relates to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds.
    Type: Application
    Filed: May 4, 2023
    Publication date: January 25, 2024
    Inventors: Jan Hinrich GUSE, Martin REISSER, Nikolas PIETRZIK, Christiane BAEUERLEIN, Kornelia EITEL
  • Patent number: 11740241
    Abstract: The disclosed technology relates to chemical entities for the detection of wounds, e.g., chronic wounds or infected wounds, including compositions, substrates, kits, dressing materials, and articles, and systems containing such compounds. The disclosed technology further relates to methods of using these compositions, kits and systems in diagnostic assays, and in the diagnosis and/or detection of chronic or infected wounds based on enzymatic action on specific moieties and/or reaction sites. The disclosed technology additionally relates to detection of pathogenic, e.g., bacterial and/or viral substances, such as enzymes and substrates, at the wound situs. Additional disclosure relates to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: August 29, 2023
    Assignee: Synovo GmbH
    Inventors: Jan Hinrich Guse, Martin Reisser, Nikolas Pietrzik, Christiane Baeuerlein, Kornelia Eitel
  • Publication number: 20230159581
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: July 26, 2022
    Publication date: May 25, 2023
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Patent number: 11420995
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: August 23, 2022
    Assignee: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Publication number: 20210088518
    Abstract: The disclosed technology relates to chemical entities for the detection of wounds, e.g., chronic wounds or infected wounds, including compositions, substrates, kits, dressing materials, and articles, and systems containing such compounds. The disclosed technology further relates to methods of using these compositions, kits and systems in diagnostic assays, and in the diagnosis and/or detection of chronic or infected wounds based on enzymatic action on specific moieties and/or reaction sites. The disclosed technology additionally relates to detection of pathogenic, e.g., bacterial and/or viral substances, such as enzymes and substrates, at the wound situs. Additional disclosure relates to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds.
    Type: Application
    Filed: March 30, 2017
    Publication date: March 25, 2021
    Inventors: Jan Hinrich GUSE, Martin REISSER, Nikolas PIETRZIK, Christiane BAEUERLEIN
  • Publication number: 20200262857
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: March 2, 2018
    Publication date: August 20, 2020
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Publication number: 20120232257
    Abstract: The invention relates to a nitration method having the following principles: a phosgene species is converted with two equivalent silver nitrates into a double-mixed anhydride of carbonic acid and nitric acid, known here as carbonic acid dinitrate (I). Said operation is carried out in situ, and the formed dinitrate decomposes spontaneously. In addition to carbon dioxide, nitrate ions and nitronium ions are formed, said ions comprising electrophiles which are necessary for nitration. The solution which is used is acetonitrile, and is insignificant if the alcohol species is dissolved or suspended. The necessary equivalent silver nitrates are introduced into the system and optionally heated or cooled to the desired temperature. Subsequently, the acid chloride is introduced slowly, drop by drop or slowly little by little. Phosgene, diphosgene, triphosgene and chloroformic acid ester can be used as carbonic acid dichloride and monochloride, and their thiocarbonic acid analogues.
    Type: Application
    Filed: October 4, 2010
    Publication date: September 13, 2012
    Applicant: SYNOVO GMBH
    Inventor: Nikolas Pietrzik